Unstable angina
Overview
Unstable angina (UA) is one of three ACS presentations. The key distinguishing feature from NSTEMI is a negative troponin - both are managed identically acutely until the result returns.
Pathophysiology
•Plaque rupture → platelet aggregation → partial (non-occlusive) thrombus → ischaemia without myocyte necrosis → troponin negative
ACS spectrum
| Feature | UA | NSTEMI | STEMI |
|---|---|---|---|
| Thrombus | Partial occlusion | Partial occlusion | Complete occlusion |
| Troponin | Negative | Positive | Positive |
| ECG | ST depression / T inversion / normal | ST depression / T inversion / normal | ST elevation |
| Myocyte necrosis | No | Yes | Yes |
Presentation
•Rest pain - central, heavy/tight, >20 minutes; or crescendo pattern breaking previous stable angina
•Radiation to jaw, left arm, or back
•Diaphoresis, dyspnoea, nausea, palpitations
•Atypical presentations (women, diabetics, elderly) - epigastric pain, fatigue, syncope, exertional dyspnoea
Investigations
🥇 First-line
•12-lead ECG - ST depression, T-wave inversion, or normal
•High-sensitivity troponin (0h/1h or 0h/3h protocol) - negative in UA by definition; rules in NSTEMI if positive
•FBC, U&Es, lipids, glucose, CXR - baseline and risk factor assessment
🏆 Gold standard
•Coronary angiography - defines anatomy, guides revascularisation; timing guided by GRACE score
Differential Diagnosis
•NSTEMI - clinically identical; differentiated by positive high-sensitivity troponin
•STEMI - ST elevation on ECG; requires immediate reperfusion
•Aortic dissection - tearing pain to back, asymmetric BP, widened mediastinum; CT angiography
•PE - pleuritic pain, dyspnoea, tachycardia; CTPA or V/Q scan
•Oesophageal spasm - may mimic angina and respond to GTN; normal ECG and troponin
Management
Immediate
- 1Admit to hospital - medical emergency
- 212-lead ECG and IV access
- 3Continuous cardiac monitoring
- 4Aspirin 300 mg loading dose (oral)
- 5Ticagrelor 180 mg loading dose (preferred) OR clopidogrel 300 mg
- 6Fondaparinux 2.5 mg SC (anticoagulation) - unless high bleeding risk
- 7GTN sublingual/IV for symptom relief
- 8Morphine IV for refractory pain (use cautiously - may delay antiplatelet absorption)
Early
- 1Beta-blocker (e.g. bisoprolol) - rate/BP control if no contraindication
- 2Atorvastatin 80 mg
- 3GRACE score to risk stratify and guide timing of angiography
High risk (GRACE >140 or refractory symptoms)
Coronary angiography within 24 hours
Intermediate risk (GRACE 109-140)
Coronary angiography within 72 hours
Low risk (GRACE <109)
Non-invasive testing or elective angiography
Follow-up
•Cardiology outpatient review typically within 6-8 weeks post-procedure
•DVLA: no driving for 1 week after successful PCI (Group 1); 4 weeks if medically managed without revascularisation
Complications
•Progression to NSTEMI/STEMI - thrombus propagates to complete occlusion
•Ventricular fibrillation and sudden cardiac death
•Acute heart failure / cardiogenic shock
Secondary Prevention
•DAPT: aspirin + ticagrelor (or clopidogrel) for 12 months, then lifelong aspirin alone
•Atorvastatin 80 mg indefinitely - target LDL-C <1.4 mmol/L or >50% reduction
•ACE inhibitor (or ARB if intolerant) - especially if reduced EF, diabetes, hypertension, or CKD
•Beta-blocker long term, especially if LV dysfunction
•Smoking cessation, BP target <130/80 mmHg, HbA1c optimisation, cardiac rehabilitation